Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma
- PMID: 16760460
- DOI: 10.1056/NEJMc053129
Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma
Erratum in
- N Engl J Med. 2006 Aug 24;355(8):856
Comment in
-
Alemtuzumab for refractory celiac disease.N Engl J Med. 2006 Sep 28;355(13):1396-7; author reply 1397. doi: 10.1056/NEJMc061784. N Engl J Med. 2006. PMID: 17005966 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical